CA2309000A1 - Systeme de transposon a base de tc1 - Google Patents

Systeme de transposon a base de tc1 Download PDF

Info

Publication number
CA2309000A1
CA2309000A1 CA002309000A CA2309000A CA2309000A1 CA 2309000 A1 CA2309000 A1 CA 2309000A1 CA 002309000 A CA002309000 A CA 002309000A CA 2309000 A CA2309000 A CA 2309000A CA 2309000 A1 CA2309000 A1 CA 2309000A1
Authority
CA
Canada
Prior art keywords
nucleic acid
cell
sequence
coding sequence
transposase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002309000A
Other languages
English (en)
Inventor
Perry B. Hackett
Karl J. Clark
Adam J. Dupuy
Stephen C. Ekker
David A. Largaespada
Zoltan Ivics
Zsuzsanna Izsvak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2309000A1 publication Critical patent/CA2309000A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/60Vectors containing traps for, e.g. exons, promoters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/90Vectors containing a transposable element
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/001Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/005Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
    • C12N2830/006Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB tet repressible
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/20Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/44Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des vecteurs de transposon codant pour des pièges à gènes et des pièges à régions de commande d'expression. La présente invention concerne également des vecteurs dicistroniques. Selon certains modes de réalisation, l'invention concerne, en outre, des sites d'entrée de ribosome interne.
CA002309000A 1997-11-13 1998-11-13 Systeme de transposon a base de tc1 Abandoned CA2309000A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6530397P 1997-11-13 1997-11-13
US60/065,303 1997-11-13
PCT/US1998/024348 WO1999025817A2 (fr) 1997-11-13 1998-11-13 Systeme de transposon a base d'adn permettant d'introduire un acide nucleique dans l'adn d'une cellule

Publications (1)

Publication Number Publication Date
CA2309000A1 true CA2309000A1 (fr) 1999-05-27

Family

ID=22061760

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002309000A Abandoned CA2309000A1 (fr) 1997-11-13 1998-11-13 Systeme de transposon a base de tc1

Country Status (5)

Country Link
EP (1) EP1034258A2 (fr)
JP (1) JP2001523450A (fr)
AU (1) AU1410399A (fr)
CA (1) CA2309000A1 (fr)
WO (1) WO1999025817A2 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489458B2 (en) 1997-03-11 2002-12-03 Regents Of The University Of Minnesota DNA-based transposon system for the introduction of nucleic acid into DNA of a cell
US7160682B2 (en) 1998-11-13 2007-01-09 Regents Of The University Of Minnesota Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell
CA2373121A1 (fr) * 1999-05-11 2000-11-16 Regents Of The University Of Minnesota Diffusion de sequences de transposon integratreur par des vecteurs
AU1292301A (en) * 1999-10-19 2001-04-30 Minos Biosystems Limited Method for genetic manipulation
WO2001030965A2 (fr) 1999-10-28 2001-05-03 The Board Of Trustees Of The Leland Stanford Junior University Methodes de transfert genique in vivo a l'aide d'un systeme de transposon «sleeping beauty»
CA2398790A1 (fr) 2000-01-28 2001-08-02 The Scripps Research Institute Procedes pour identifier des elements regulateurs transcriptionnels et translationnels synthetiques, et compositions correspondantes
AU2001265756A1 (en) * 2000-04-27 2001-11-07 Max-Delbruck-Centrum Fur Molekulare Medizin Sleeping beauty, a transposon vector with a broad host range for the genetic transfprmation in vertebrates
US20020115216A1 (en) * 2000-05-19 2002-08-22 Steer Clifford J. Composition for delivery of compounds to cells
US8227432B2 (en) 2002-04-22 2012-07-24 Regents Of The University Of Minnesota Transposon system and methods of use
DE10224242A1 (de) * 2002-05-29 2003-12-11 Max Delbrueck Centrum Frog Prince, ein Transposonvektor für den Gentransfer bei Wirbeltieren
US7985739B2 (en) 2003-06-04 2011-07-26 The Board Of Trustees Of The Leland Stanford Junior University Enhanced sleeping beauty transposon system and methods for using the same
US7919583B2 (en) 2005-08-08 2011-04-05 Discovery Genomics, Inc. Integration-site directed vector systems
US9228180B2 (en) 2007-07-04 2016-01-05 Max-Delbruck-Centrum Fur Molekulare Medizin Polypeptide variants of sleeping beauty transposase
WO2011153440A2 (fr) 2010-06-04 2011-12-08 Regents Of The University Of Minnesota Système de mutagenèse par transposons et ses méthodes d'utilisation
EP3092308A1 (fr) 2014-01-07 2016-11-16 Fundacio Privada Institut de Medicina Predictiva i Personalitzada del Cancer Procédé de génération de banques adn double brin et procédés de séquençage pour l'identification des cytosines méthylées
WO2019010551A1 (fr) * 2017-07-10 2019-01-17 Instituto De Biologia Molecular Do Paraná - Ibmp Plateforme génétique pour la surexpression hétérologue associée à la sélection de cellules hautement productrices de protéines
WO2019027850A1 (fr) 2017-07-29 2019-02-07 Juno Therapeutics, Inc. Réactifs d'expansion de cellules exprimant des récepteurs recombinants
US20210254000A1 (en) 2017-11-01 2021-08-19 Juno Therapeutics, Inc. Process for producing a t cell composition
CN111542596A (zh) 2017-11-01 2020-08-14 朱诺治疗学股份有限公司 产生工程化细胞的治疗性组合物的方法
BR112020011215A2 (pt) 2017-12-08 2020-11-17 Juno Therapeutics Inc processo para a produção de uma composição de células t modificadas
WO2021092097A1 (fr) 2019-11-05 2021-05-14 Juno Therapeutics, Inc. Procédés de détermination d'attributs de compositions de cellules t thérapeutiques
JP2023520083A (ja) * 2020-03-30 2023-05-15 中国科学院動物研究所 活性dnaトランスポゾンシステム及びその使用方法
EP4150640A1 (fr) 2020-05-13 2023-03-22 Juno Therapeutics, Inc. Procédés d'identification de caractéristiques associées à une réponse clinique et leurs utilisations
US20240168012A1 (en) 2021-03-22 2024-05-23 Juno Therapeutics, Inc. Methods of determining potency of a therapeutic cell composition
WO2023122716A1 (fr) 2021-12-22 2023-06-29 Vanderbilt University Transpososomes de nouvelle génération
WO2023230548A1 (fr) 2022-05-25 2023-11-30 Celgene Corporation Procédé de prédiction d'une réponse à une thérapie par lymphocyte t
US20240000844A1 (en) 2022-05-27 2024-01-04 Kite Pharma, Inc. Non-viral delivery of cell therapy constructs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0885307A1 (fr) * 1996-02-09 1998-12-23 Vereniging Het Nederlands Kanker Instituut Vecteurs et methodes afferentes permettant d'apporter a des cellules des acides nucleiques supplementaires s'integrant dans leur genome
US6489458B2 (en) * 1997-03-11 2002-12-03 Regents Of The University Of Minnesota DNA-based transposon system for the introduction of nucleic acid into DNA of a cell

Also Published As

Publication number Publication date
WO1999025817A9 (fr) 1999-09-10
EP1034258A2 (fr) 2000-09-13
JP2001523450A (ja) 2001-11-27
WO1999025817A2 (fr) 1999-05-27
AU1410399A (en) 1999-06-07
WO1999025817A3 (fr) 1999-08-05

Similar Documents

Publication Publication Date Title
US7160682B2 (en) Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell
US6489458B2 (en) DNA-based transposon system for the introduction of nucleic acid into DNA of a cell
CA2309000A1 (fr) Systeme de transposon a base de tc1
WO1998040510A9 (fr) Systeme transposon a base d'adn permettant d'introduire de l'acide nucleique dans l'adn d'une cellule
JP2022095633A (ja) ヌクレアーゼ非依存的な標的化遺伝子編集プラットフォームおよびその用途
Wu et al. A protocol for constructing gene targeting vectors: generating knockout mice for the cadherin family and beyond
JP3298842B2 (ja) 外来性遺伝子のゲノム上部位特異的挿入により作製されたトランスジェニック又はキメラ動物
WO2000065042A1 (fr) Vecteurs derives de l'element p et procedes d'utilisation
JP2004357716A (ja) 人工染色体、該染色体の使用および人工染色体の製造方法
MX2007014139A (es) Piggybac como una herramienta para manipulacion genetica y analisis en vertebrados.
JP2009542228A (ja) 定方向進化による触媒作用のために最適化されたキメラジンクフィンガーリコンビナーゼ
WO2011101696A1 (fr) Système de recombinaison de méganucléase amélioré
EP1187938B1 (fr) Procede d'expression de transgenes dans la lignee germinale de caenorhabditis elegans
EP1222262B1 (fr) Construction de piegeage de genes conditionnel pour la disruption genetique
US20030143731A1 (en) Use of heterologous transcription factors in gene therapy
WO2005054463A1 (fr) Mise au point d'une technique de modification du genome d'un mammifere a l'aide d'un retrotransposon
JP2004530429A (ja) 転写活性な座を標的化する方法
EP1308516A1 (fr) Protéines de fusions à activité recombinase ciblée et les polynucléotides, vecteurs et kits correspondants, ainsi que leur utilisation pour la recombinaison ciblée de l'ADN
WO1998040468A1 (fr) Procedes permettant de construire une banque de mutations geniques, composes et compositions associes
US20210332387A1 (en) Genetic data compression and methods of use
US7196244B1 (en) Method of transposon-mediated mutagenesis in the nematode caenorhabditis elegans
Kumari et al. Transgenic animals in biotechnology
Clark The development of Sleeping Beauty gene-trap transposons for insertional mutagenesis of vertebrates
Thomson Optimizing integration events in the Cre/loxP system

Legal Events

Date Code Title Description
FZDE Discontinued